Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2012
03/21/2012EP2430047A2 Neutralizing molecules to influenza viruses
03/21/2012EP2430046A1 Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
03/21/2012EP2430045A2 Carbohydrate binding module and use thereof
03/21/2012EP2430039A1 Ttk peptides and vaccines including the same
03/21/2012EP2429584A2 Methods and compositions for treatment
03/21/2012EP2429582A2 Anti-human cd52 immunoglobulins
03/21/2012EP2167531B1 Streptococcus pneumoniae pilus antigens
03/21/2012EP2074147B1 Antibodies against ccr5 and uses thereof
03/21/2012EP1966244B1 Anti-il-6 antibodies preventing the binding of il-6 complexed with il-6ralpha to gp130
03/21/2012EP1853629B1 Human ring specific bnp antibodies
03/21/2012EP1688488B9 Bispecific antibody substituting for factor viii
03/21/2012EP1664321B1 Methods for expression and purification of immunotoxins
03/21/2012EP1528935B1 Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody
03/21/2012EP1461428B1 Method for producing hybrid antibodies
03/21/2012EP1436624B1 A method of diagnosis and treatment and agents useful for same
03/21/2012CN1756843B Streptococcus pyogenes antigens
03/21/2012CN102388307A Diagnosis of multiple sclerosis
03/21/2012CN102388140A Aberrant mitochondrial DNA, associated fusion transcripts and translation products and hybridization probes therefor
03/21/2012CN102388135A Protease for wound conditioning and skin care
03/21/2012CN102388069A Improved amino acid sequences directed against IL-6R and polypeptides comprising the same for the treatment of IL-6R related diseases and disorders
03/21/2012CN102388068A Alpha-4-beta-7 heterodimer specific antagonist antibody
03/21/2012CN102388067A Targeted binding agents directed to cd105 and uses thereof
03/21/2012CN102388066A Antibody molecules having binding specificity for human IL-13
03/21/2012CN102388065A DKK-1 antibodies
03/21/2012CN102388064A Compositions and methods for screening and using compounds antagonizing spore-surface interactions
03/21/2012CN102388063A Methods for inducing transplantation tolerance
03/21/2012CN102387815A Amatoxin-armed target-binding moieties for the treatment of cancer
03/21/2012CN102387814A Human anti-il-6 antibodies with extended in vivo half-life and their use in treatment of oncology, autoimmune diseases and inflammatory diseases
03/21/2012CN102380097A Peptide-based passive immunization therapy for treatment of atherosclerosis
03/21/2012CN101906159B Hybridoma cell line D6D
03/21/2012CN101555283B Antibodies to non-functional p2x7 receptor, diagnosis and treatment of cancers and other conditions
03/21/2012CN101177700B Methods and means for producing proteins with predetermined post-translational modifications
03/21/2012CN101006176B Polypeptide having activity of unsaturating omega3-fatty acid, polynucleotide coding for the polypeptide and use thereof
03/20/2012US8139715 Method and composition for crystallizing G protein-coupled receptors
03/20/2012US8138389 Method for modifying plant morphology, biochemistry and physiology
03/20/2012US8138323 Cytokines; side effect reduction; bactericides; antitumor agents; anticarcinogenic agents
03/20/2012US8138322 Human T1R2 nucleic acid sequences and polypeptides
03/20/2012US8138316 Feline pancreatic lipase
03/20/2012US8138314 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
03/20/2012US8138313 Treatment of tumors using specific anti-L1 antibody
03/20/2012US8138311 Modified proteins, designer toxins, and methods of making thereof
03/20/2012US8138142 Methods for increasing adiponectin in a patient in need thereof
03/20/2012US8138141 HMG1 antibody for treating inflammatory conditions
03/20/2012US8138140 Self-assembling peptide amphiphiles and related methods for growth factor delivery
03/20/2012US8137989 Method for delivering a cytokine using a colloidal metal
03/20/2012US8137960 Bovine adeno-associated viral (BAAV) vector and uses thereof
03/20/2012US8137933 Mammalian expression vector pUHAB
03/20/2012US8137932 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment
03/20/2012US8137923 Glycoprotein VI and uses thereof
03/20/2012US8137915 Genes involved in intestinal inflammatory diseases and use thereof
03/20/2012US8137907 Orthotopic and genetically tractable non-human animal model for liver cancer and the uses thereof
03/20/2012US8137678 Canine lyme disease vaccine
03/20/2012US8137675 Bont/a peptides and methodsof predicting and reducing immunoresistance to botulinum toxin therapy
03/20/2012US8137668 Methods and compositions for generating human monoclonal antibodies
03/20/2012US8137667 Fully human antibodies against human 4-1BB
03/20/2012CA2622180C Method for generating f(ab')2 antibody fragments
03/20/2012CA2474801C Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity
03/20/2012CA2471114C Mutant b-raf polypeptide and a use thereof in the diagnosis of cancer
03/20/2012CA2441292C Equine herpesvirus vaccine
03/20/2012CA2435683C Hybridoma cell line g250 and its use for producing monoclonal antibodies
03/20/2012CA2429172C Novel mutant allergens
03/20/2012CA2360020C Methods for differentiating and monitoring parathyroid and bone status related diseases
03/20/2012CA2348755C Polypeptide compositions toxic to diabrotica insects, obtained from bacillus thuringiensis; cryet70, and methods of use
03/20/2012CA2299560C Human defensin def-x, gene and dnac, composition containing same and diagnostic and therapeutic applications
03/20/2012CA2296842C Ligands, including antibodies, showing reactivity against endocrine cells
03/17/2012CA2752396A1 Pertussis antibodies and uses thereof
03/15/2012WO2012034039A2 Anti-il-1 beta antibodies and methods of use
03/15/2012WO2012034025A2 Human cytomegalovirus vaccine
03/15/2012WO2012033987A2 Anti-human folate receptor beta antibodies and methods of use
03/15/2012WO2012033953A1 Methods for assessing and identifying or evolving conditionally active therapeutic proteins
03/15/2012WO2012033696A1 Anti-vegfr-3 antibody compositions
03/15/2012WO2012032763A1 Vangl1 peptides and vaccines including the same
03/15/2012WO2012032433A1 4-1bb binding molecules
03/15/2012WO2012032181A2 Novel antibody derivatives
03/15/2012WO2012032143A1 Phosphorylated twist1 and metastasis
03/15/2012WO2012032080A1 Stabilised human fc
03/15/2012WO2012031744A1 Chimeric antigen receptors with an optimized hinge region
03/15/2012WO2011162904A3 Multidomain biotags for cancer detection, diagnosis and therapy and methods of their use priority statement
03/15/2012WO2011153477A3 Uses and compositions for treatment of hidradenitis suppurativa (hs)
03/15/2012WO2011147982A3 Monoclonal antibodies against her2 epitope
03/15/2012WO2011146885A3 Compositions and methods for lentiviral expression of apoa-1 or variants thereof using spliceosome mediated rna trans-splicing
03/15/2012WO2011045352A3 Spleen tyrosine kinase and brain cancers
03/15/2012US20120066780 Humanized nsg mouse, method of producing the same and use thereof
03/15/2012US20120066777 Test agent for visceral obesity and use thereof
03/15/2012US20120066776 Identification of a jak2 mutation involved in vaquez polyglobulia
03/15/2012US20120065385 Dendritic cell co-stimulatory molecules
03/15/2012US20120065381 Protein purification
03/15/2012US20120065379 Antibody Constant Region Variant
03/15/2012US20120065374 Dendritic cell co-stimulatory molecules
03/15/2012US20120065149 Vitamin receptor binding drug delivery conjugates
03/15/2012US20120065148 Phosphodiesterase 4d7 as prostate cancer marker
03/15/2012US20120065100 Phosphodiesterase 9a as prostate cancer marker
03/15/2012US20120065094 Methods and kits for diagnosing osteoarthritis and predicting progression
03/15/2012US20120064626 B7-h7 antibodies and method of use
03/15/2012US20120064600 Anti-5t4 antibodies and uses thereof
03/15/2012US20120064598 Mutation of the parkin gene, compositions, methods and uses
03/15/2012US20120064572 Bacterial Virulence Factors And Uses Thereof
03/15/2012US20120064571 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
03/15/2012US20120064548 Novel genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
03/15/2012US20120064544 Methods of Diagnosing Hypophosphatemic Disorders
1 ... 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 ... 1494